| 09355529000033 - T1CMR Phantom (1.5T) | 2024-04-25 The T1CMR Phantom contains a range of nickel chloride in agarose solutions that mimic cardiac T1 and T2 values. T1 measurement i |
| 09355529000064 - T1CMR Phantom (3.0T) | 2024-04-25 The T1CMR Phantom contains a range of nickel chloride in agarose solutions that mimic cardiac T1 and T2 values. T1 measurement i |
| 09355529000071 - T2CMR Phantom | 2024-04-25 Cardiovascular magnetic resonance (CMR) T2 mapping is key to quantifying myocardial inflammation. The T2CMR Phantom is made of n |
| 09355529000088 - R2*/T2* Phantom | 2024-04-25 The R2*/T2* phantom is a medical device accessory intended to be used as an alternative to human test subject to avoid potential |
| 09355529000026 - FerriScan Phantom | 2024-04-18 Sealed pack containing 15 vials of varying concentrations (0 mM to 3.2 mM) of aqueous manganese chloride solutions in 10 mM hydr |
| 09355529000002 - FerriScan, Cardiac T2* | 2023-06-27 Software tool to facilitate the import and visualization of multi slice, spin echo MRI data sets encompassing the liver and card |
| 09355529000019 - HepaFat-AI | 2023-06-26Standalone software platform designed to automatically analyse within seconds magnetic resonance imaging (MRI) datasets to generate an estimate of the patient’s volumetric liver fat fraction (VLFF), converted into proton density fat fraction (PDFF) and steatosis grade. No user input is required for the analysis thus minimising the impact of human error on obtained results.
HepaFat-AI is intended for quantitative measurement of the triglyceride fat fraction in magnetic resonance images of the liver, also known as volumetric liver fat fraction (VLFF).
It utilises magnetic resonance images that exploit the difference in resonance frequencies between hydrogen nuclei in water and triglyceride fat. The quantitative triglyceride fat fraction is based on the measurement of a magnetic resonance parameter that reflects the ratio of the proton density signal of triglyceride fat to the total proton density signal in the liver.
When interpreted by a trained physician, the results provide information that can aid in diagnosis.
HepaFat-AI is indicated to:
• Assess the volumetric liver fat fraction, proton density fat fraction and steatosis grade in individuals with confirmed or suspected fatty liver disease;
• Monitor liver fat content in patients undergoing weight loss management;
• Aid in the assessment and screening of living donors for liver transplant. |
| 09355529000019 - HepaFat-AI | 2023-06-26 Standalone software platform designed to automatically analyse within seconds magnetic resonance imaging (MRI) datasets to gener |
| 09355529000040 - HepaFat-Scan | 2023-06-26 Standalone software application to facilitate the import and visualization of multi slice, gradient echo MRI data sets encompass |